V&Co
V&Co is a South Korea-based K-Beauty company developing SKINBIOME, a skin microbiome diagnostic technology for personalized skincare. Founded in 2015 and headquartered in Seoul with a Bio Research Center in Suwon, the company targets global K-Beauty expansion under CEO Choi Won-seok.
- Company typePrivate
- Founded2015
- HeadquartersSeoul, South Korea
- Headcount11–50
- GTM typeB2B and B2C
- OfferingServices
V&Co firmographics
Firmographics- Name
- V&Co
- Legal name
- V&CO
- Website
- https://vnco.co.kr
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- V&Co is a South Korea-based K-Beauty company developing SKINBIOME, a skin microbiome diagnostic technology for personalized skincare. Founded in 2015 and headquartered in Seoul with a Bio Research Center in Suwon, the company targets global K-Beauty expansion under CEO Choi Won-seok.
- Ownership category
- akta.pro rank
V&Co industry classification
Industry- Product category
- K-Beauty Skin Diagnostics
- NAICS
- Medical and Diagnostic Laboratories (62151), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Perfumes, Cosmetics & Other Toilet Preparations (2844), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- At-Home Lab Testing & Diagnostics-Integrated Virtual Care (HLALAAAE)
Keywords
Where V&Co is headquartered
LocationHeadquarters
- HQ city
- Seoul
- HQ country
- South Korea
- HQ region
- Asia
Offices2 records
Markets served
V&Co business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
V&Co product offering
Product offeringCore offering
V&Co is a K-Beauty medical specialist company that develops and delivers SKINBIOME, a skin diagnostic innovation based on skin microbiome analysis. The company offers personalized skincare solutions and advanced dermatology/plastic surgery services by leveraging proprietary microbiome profiling technology. Its mission is to change the world in the beauty and health medical industry.
Differentiator
Problem solved
Functional benefit
Brands
- SKINBIOME: 피부 진단의 혁신 스킨바이옴 (Skin diagnosis innovation - Skinbiome)
Products and services
- SKINBIOME Proprietary skin diagnostic innovation that uses skin microbiome analysis to generate personalized skincare insights and recommendations, intended for both individual consumers and medical/aesthetic clinics in dermatology and plastic surgery.
Companies that use V&Co
Customer profileIdeal customer profiles2 records
V&Co technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
V&Co competitors and assessment
Company assessmentBroad incumbents
- Amorepacific: Korea's largest beauty conglomerate with global skincare brands (Sulwhasoo, Innisfree, Laneige). Relevant as the dominant incumbent against which any K-beauty global expansion play is benchmarked; V&Co's stated mission mirrors Amorepacific's internationalization trajectory.
- LG Household & Health Care: Major Korean personal-care and beauty group (The History of Whoo, Su:m37°, O HUI). Comparable as a Korean beauty conglomerate pursuing global premium skincare positioning; competes for similar retail and clinician channels.
Direct peers
- Mother Dirt: US-based skincare brand built around skin microbiome science. Directly comparable to V&Co's SKINBIOME positioning as a microbiome-anchored skincare proposition and serves as the closest functional analog for V&Co's diagnostic-plus-product thesis.
- Tirtir: Korean beauty brand with viral global growth built around a hero product (Mask Fit Red Cushion). Comparable Korean indie-to-global commercial trajectory and benchmark for what scale a Korean indie brand can reach internationally.
- S-Biomedic: Belgian skin microbiome company developing live bacterial therapeutics and microbiome-based skincare. Comparable technology stack (skin microbiome R&D applied to cosmetic/dermatological use) and similar early-commercial-stage profile to V&Co.
- Beauty of Joseon: Fast-growing Korean skincare DTC brand that scaled globally via digital channels. Comparable as a small Korean skincare brand demonstrating the K-beauty global expansion playbook V&Co is pursuing.
- Cosrx: Korean skincare brand built on dermatologist-recommended formulations, widely distributed globally through Sephora and Amazon. Comparable Korean indie-brand-to-global trajectory that V&Co's K-beauty pioneer narrative implies.
- Gallinée: Skincare brand and microbiome-focused product line acquired by Unilever. Comparable as a consumer-facing microbiome skincare brand with R&D backing; relevant benchmark for V&Co's potential B2B licensing or acquisition pathway.
- AO Biome: US biotech developing live bacterial therapeutics for skin conditions including acne and eczema. Comparable as a science-first skin microbiome company operating at the dermatology/skincare boundary that V&Co's positioning targets.
Emerging players
- Dermala: US-based skin microbiome startup combining diagnostics with personalized skincare products. Comparable business model (microbiome analysis + customized skincare) and similar early-stage profile to V&Co's SKINBIOME offering.
Market position
Customer concentration
V&Co financial estimates
Financial estimateRevenue estimate
Valuation estimate
V&Co leadership team
Management profileNumber of profiles
Profiles1 record
V&Co funding detail
Funding detailFunding overview
Funding rounds1 record
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
V&Co M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about V&Co
What does V&Co do?
V&Co is a K-Beauty medical specialist company that develops and delivers SKINBIOME, a skin diagnostic innovation based on skin microbiome analysis. The company offers personalized skincare solutions and advanced dermatology/plastic surgery services by leveraging proprietary microbiome profiling technology. Its mission is to change the world in the beauty and health medical industry.
Is V&Co a public or private company?
V&Co is a private company. It is classified as venture growth investor backed and is currently operating.
When was V&Co founded?
V&Co was founded in 2015. It employs 11 to 50 people.
Where is V&Co based?
V&Co is headquartered in Seoul, South Korea, in the Asia region.
Who are V&Co's main competitors?
Broad incumbents on record are Amorepacific and LG Household & Health Care. Direct peers are Mother Dirt, Tirtir, S-Biomedic, Beauty of Joseon, Cosrx, Gallinée and AO Biome. Dermala is listed as an emerging player.
Does V&Co have an API?
No public API is recorded for V&Co.
What industry is V&Co in?
V&Co's product category is K-Beauty Skin Diagnostics. Its primary akta.pro industry code is HLALAAAE, At-Home Lab Testing & Diagnostics-Integrated Virtual Care. Its NAICS code is 62151 and its SIC code is 2844.